close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

68.83 +0.61 (+0.90%)
Delayed Quote Updated: 1:43 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
From Ambry Genetics
Via Business Wire
News headline image
Tempus Announces Multi-Year Collaboration with Moderna and Merck
From Tempus
Via Business Wire
News headline image
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
From Tempus AI, Inc.
Via Business Wire
Tempus AI (NASDAQ:TEM) Delivers Mixed Q2 Results with EPS Beat, Stock Slips in After-Hours Trading ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Tempus AI Chief Accounting Officer Sells $529,650 of Stock ↗
Sale follows 30% rebound in the stock year to date. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion ↗
Tempus AI (NASDAQ:TEM) Founder and CEO Eric Lefkofsky said the company’s second-quarter performance was supported by continued demand for comprehensive genomic profiling and growth in its... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology
From Tempus AI, Inc.
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 ↗
Sale executed under pre-established Rule 10b5-1 trading plan adopted in May, leaving West with 31,981 shares and a 0.0183% ownership stake. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Cathie Wood Invested Roughly $1.4 Billion of Ark Invest's Flagship ETF in Just 3 Artificial Intelligence (AI) Stocks ↗
Wood is known for being a tech-first investor. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Earnings
News headline image
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
From Tempus AI, Inc.
Via Business Wire
News headline image
Why Tempus AI Skyrocketed This Week ↗
Tempus AI's latest acquisition is looking like a great move. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
A Tempus AI Director Sold Stock Four Days Before a 24% Rally. Here's What to Know ↗
West executed a sale under a pre-established Rule 10b5-1 trading plan, reducing her direct stake by 8% while retaining 34,981 shares worth roughly $1.8 million. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade ↗
Polovin's sale of 30,075 shares was non-discretionary and tied to tax withholding from RSU vesting. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Accounting Chief Just Reported an Insider Transaction. Here's What Long-Term Investors Should Know ↗
Bartolucci disposed of shares valued at $306,342 to cover statutory withholding obligations tied to RSU vesting, retaining direct holdings of 67,866 shares worth $3.35 million. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
What to Know About the CFO of Tempus AI's Latest Insider Transaction Filing ↗
This non-discretionary sale to cover RSU withholding obligations reduced his direct stake, but he retains about 106,000 shares valued at $6.49 million. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened ↗
These sales were driven by tax withholding obligations tied to restricted stock unit vesting under a pre-established trading plan. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Data Chief Just Filed a Form 4. His Segment Grew 28% Last Quarter. ↗
This sale was non-discretionary, executed to cover tax withholding from RSU vesting. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's CEO Sold $6.6 Million in Stock the Day Before a Huge Rally. Here's What to Know ↗
This filing details a non-discretionary sale that reduced Lefkofsky's direct holdings by a small percentage. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
AI Found an Influenza Target That Survives Viral Mutation
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) 
From Equity Insider
Via GlobeNewswire
News headline image
Why Is Tempus AI Stock Surging on Friday? ↗
Tempus AI Inc. (NASDAQ: TEM) stock jumped on Friday, August 7, 2026, following strong AI healthcare peer earnings from Doximity Inc. and a strategic lab expansion with CellCarta. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Q2 Earnings Call Highlights ↗
Tempus AI (NASDAQ:TEM) reported second-quarter revenue growth of 22% and raised its full-year outlook, citing accelerating oncology testing volumes, expanding demand for its data and artificial... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Tempus AI Stock Slides Friday: What's Driving the Post-Earnings Reset? ↗
Tempus AI Inc. (NASDAQ: TEM) shares are trading lower Friday as traders digest post-earnings reset in expectations. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Is Tempus AI Stock a Buy After Its CEO Sold 250,000 Shares? ↗
Tempus AI's founder-CEO reduced an indirect stake by about 4% through a pre-scheduled trading plan, retaining roughly 6.5 million shares as the company pursues a major acquisition. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.